• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

BIO Protocol and NuDAO Join Forces to Accelerate Decentralized Science Development

user avatar

by Giorgi Kostiuk

10 months ago


BIO Protocol and NuDAO have entered into a partnership aimed at strengthening the decentralized science ecosystem through strategic resource allocation and collaboration.

A Transformative Partnership

A recent press release announced NuDAO's strategic allocation of 6.9% of its treasury to BIO Protocol, highlighting a long-term collaboration to accelerate the decentralized science ecosystem. This partnership combines NuDAO's technological expertise in biotech and AI with BIO Protocol's established DeSci infrastructure.

This strategic partnership demonstrates our confidence in BIO Protocol’s vision and our shared commitment to advancing decentralized science.NuDAO

Key Elements of the Partnership

The partnership includes scientific and technical collaborations: * Joint Development: NuDAO and BIO Protocol will collaborate on significant scientific research initiatives, focusing on IP and NFT development. * Co-Incubation Projects: Both organizations will incubate promising research projects together, providing shared resources and expertise. * Governance: Both entities will actively participate in each other's governance frameworks, promoting collaboration and shared decision-making in DeSci development.

The Role of the CRISPR Token

A key component of the partnership is the integration of NuDAO's CRISPR token, which powers the research ecosystem. CRISPR will gain access to BIO Protocol’s research resources, driving innovation. CRISPR token holders will have the opportunity to participate in key decisions, influencing the future of decentralized science. The collaboration will enhance CRISPR’s position within the broader DeSci network, unlocking opportunities for growth and innovation.

The partnership aims to create a global decentralized research community enabling borderless collaboration. It supports the commercialization of biotech innovations, such as rare disease research and longevity research.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

DeFiChain Shows Potential with 137K Events

chest

DeFiChain DFI posts 137K events, indicating potential upgrades and renewed interest in the token.

user avatarLi Weicheng

Deepbook Protocol Gains Momentum with 1.321M Events

chest

Deepbook Protocol DEEP secures third place in DeFi development, indicating a rise in concentrated liquidity mechanisms on the Sui network. This activity signals growing momentum in the DeFi space.

user avatarTenzin Dorje

Lido DAO and ShapeShift Maintain Steady Progress

chest

Established players Lido DAO and ShapeShift continue to show steady development in the DeFi space.

user avatarLi Weicheng

Chainlink Leads DeFi Development with 3.296M GitHub Events

chest

Chainlink LINK showcases significant innovation in decentralized oracles, leading the DeFi space with the highest number of GitHub events.

user avatarAisha Farooq

Key Takeaways from Upbit's Unauthorized Withdrawal Incident

chest

The Upbit unauthorized withdrawal incident highlights key lessons for cryptocurrency exchanges and users.

user avatarBayarjavkhlan Ganbaatar

BitValue Capital and Neural Trust Foundation Discuss Partnership

chest

BitValue Capital recently met with Neural Trust Foundation to discuss a potential partnership focused on AI blockchain distribution models.

user avatarMohamed Farouk

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.